Financials SKAN Group AG

Equities

SKAN

CH0013396012

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange Other stock markets 11:31:29 2024-06-10 am EDT			5-day change	1st Jan Change
82.4 ^CHF	0.00%		+2.36%	+1.98%

May. 31	Skan Group Boosts Interest in Belgian Unit Aseptic Technologies to 90%	MT
Mar. 26	Transcript : SKAN Group AG, 2023 Earnings Call, Mar 26, 2024

Valuation

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Capitalization ¹	1,992	1,416	1,817	1,853	-	-
Enterprise Value (EV) ¹	1,876	1,322	1,738	1,767	1,761	1,733
P/E ratio	105 x	75 x	69.1 x	53.2 x	37.5 x	36.8 x
Yield	0.27%	0.4%	0.43%	0.59%	0.73%	0.61%
Capitalization / Revenue	8.5 x	5.11 x	5.68 x	4.85 x	4.05 x	3.61 x
EV / Revenue	8.01 x	4.77 x	5.43 x	4.63 x	3.85 x	3.38 x
EV / EBITDA	61.1 x	32.9 x	34.7 x	28.8 x	22.6 x	21.5 x
EV / FCF	-65.3 x	37.4 x	-69.7 x	101 x	102 x	47.1 x
FCF Yield	-1.53%	2.67%	-1.43%	0.99%	0.98%	2.12%
Price to Book	12.5 x	9 x	10.7 x	8.49 x	7.13 x	6.8 x
Nbr of stocks (in thousands)	22,484	22,484	22,484	22,484	-	-
Reference price ²	88.60	63.00	80.80	82.40	82.40	82.40
Announcement Date	4/5/22	3/28/23	3/26/24	-	-	-

¹CHF in Million²CHF

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Net sales ¹	234.3	277	320	381.6	457.6	512.9
EBITDA ¹	30.68	40.15	50.14	61.35	77.9	80.5
EBIT ¹	23.06	29.46	37.75	48.7	62.05	60.7
Operating Margin	9.84%	10.64%	11.8%	12.76%	13.56%	11.83%
Earnings before Tax (EBT) ¹	24.73	25.24	32.79	49.2	62.55	60.7
Net income ¹	21.4	18.99	26.31	35	49.45	50.3
Net margin	9.13%	6.86%	8.22%	9.17%	10.81%	9.81%
EPS ²	0.8400	0.8400	1.170	1.550	2.195	2.240
Free Cash Flow ¹	-28.7	35.35	-24.93	17.5	17.2	36.8
FCF margin	-12.25%	12.77%	-7.79%	4.59%	3.76%	7.17%
FCF Conversion (EBITDA)	-	88.05%	-	28.52%	22.08%	45.71%
FCF Conversion (Net income)	-	186.21%	-	50%	34.78%	73.16%
Dividend per Share ²	0.2400	0.2500	0.3500	0.4850	0.6050	0.5000
Announcement Date	4/5/22	3/28/23	3/26/24	-	-	-

¹CHF in Million²CHF

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December	2022 S1	2023 S1
Net sales ¹	120.9	139.7
EBITDA ¹	10.68	18.6
EBIT ¹	-	12.4
Operating Margin	-	8.87%
Earnings before Tax (EBT) ¹	-	10.24
Net income ¹	-	7.804
Net margin	-	5.58%
EPS	-	-
Dividend per Share	-	-
Announcement Date	8/23/22	8/22/23

¹CHF in Million

Estimates

Balance Sheet Analysis

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Net Debt ¹	-	-	-	-	-	-
Net Cash position ¹	116	94.1	78.6	86	91.5	120
Leverage (Debt/EBITDA)	-	-	-	-	-	-
Free Cash Flow ¹	-28.7	35.4	-24.9	17.5	17.2	36.8
ROE (net income / shareholders' equity)	10.5%	-	-	-	-	-
ROA (Net income/ Total Assets)	3.59%	-	-	-	-	-
Assets ¹	596.1	-	-	-	-	-
Book Value Per Share ²	7.100	7.000	7.530	9.710	11.60	12.10
Cash Flow per Share ²	0.8200	2.730	0.3900	2.050	2.950	-
Capex ¹	39	26.1	33.6	37	49.6	35.9
Capex / Sales	16.66%	9.43%	10.51%	9.69%	10.83%	7%
Announcement Date	4/5/22	3/28/23	3/26/24	-	-	-

¹CHF in Million²CHF

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for SKAN Group AG

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

82.4 CHF

Average target price

97.5 CHF

Spread / Average Target

+18.33%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
SKAN GROUP AG	+1.98%	2.07B
SHOCKWAVE MEDICAL	+75.69%	12.57B
MASIMO CORPORATION	+8.49%	6.66B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+15.10%	5.5B
GETINGE AB	-18.30%	4.88B
APT MEDICAL INC.	+14.96%	4.1B
ASAHI INTECC CO., LTD.	-20.83%	3.89B
INARI MEDICAL, INC.	-28.50%	2.83B
NOVOCURE LIMITED	+43.74%	2.31B
SHENZHEN YHLO BIOTECH CO., LTD.	+9.75%	1.97B

Medical Equipment